中国数字医学
中國數字醫學
중국수자의학
CHINA DIGITAL MEDICINE
2015年
4期
20-23
,共4页
邵莹%白晶晶%李晨霞%付浩%孙亲丽%张月浪%刘军%杨健
邵瑩%白晶晶%李晨霞%付浩%孫親麗%張月浪%劉軍%楊健
소형%백정정%리신하%부호%손친려%장월랑%류군%양건
磁共振引导下聚焦超声(MR-HIFU)%子宫肌瘤%筛查标准
磁共振引導下聚焦超聲(MR-HIFU)%子宮肌瘤%篩查標準
자공진인도하취초초성(MR-HIFU)%자궁기류%사사표준
MR-HIFU (Magnetic Resonance-guided high-intensity focused ultrasound)%uterine fibroids%screening criteria
目的:建立MR-HIFU治疗前对患者的影像学筛查标准以及治疗的意义。方法:收集医院自2012年9月-2013年12月临床确诊为子宫肌瘤、已生育、未绝经的育龄妇女105例,行盆腔MR检查并根据临床及影像学纳入和排除标准进行评价。结果:本组筛查的105例子宫肌瘤患者中,年龄36-49岁,平均年龄45.7岁。体内有节育环1例和下腹部有明显疤痕1例被直接排除。103例行磁共振平扫检查,87例行磁共振增强检查;肌瘤单发87例,其中I型54例,II型27例,III型6例;多发12例,其中I型7例,II型3例,III型2例,6例被排除。单发病例中子宫肌瘤位置偏后,靠近骶骨5例,肌瘤中心距皮肤≥10cm的7例;子宫腺肌症4例;超声聚焦野内有肠管无法避开2例;T2加权像显示高信号和混杂信号的子宫肌瘤38例。合计排除62例,排除率59.05%。43例纳入MR-HIFU治疗,入组率40.95%。结论:通过对子宫肌瘤患者的磁共振影像学筛查标准的建立,提高了MR-HIFU治疗的安全性。
目的:建立MR-HIFU治療前對患者的影像學篩查標準以及治療的意義。方法:收集醫院自2012年9月-2013年12月臨床確診為子宮肌瘤、已生育、未絕經的育齡婦女105例,行盆腔MR檢查併根據臨床及影像學納入和排除標準進行評價。結果:本組篩查的105例子宮肌瘤患者中,年齡36-49歲,平均年齡45.7歲。體內有節育環1例和下腹部有明顯疤痕1例被直接排除。103例行磁共振平掃檢查,87例行磁共振增彊檢查;肌瘤單髮87例,其中I型54例,II型27例,III型6例;多髮12例,其中I型7例,II型3例,III型2例,6例被排除。單髮病例中子宮肌瘤位置偏後,靠近骶骨5例,肌瘤中心距皮膚≥10cm的7例;子宮腺肌癥4例;超聲聚焦野內有腸管無法避開2例;T2加權像顯示高信號和混雜信號的子宮肌瘤38例。閤計排除62例,排除率59.05%。43例納入MR-HIFU治療,入組率40.95%。結論:通過對子宮肌瘤患者的磁共振影像學篩查標準的建立,提高瞭MR-HIFU治療的安全性。
목적:건립MR-HIFU치료전대환자적영상학사사표준이급치료적의의。방법:수집의원자2012년9월-2013년12월림상학진위자궁기류、이생육、미절경적육령부녀105례,행분강MR검사병근거림상급영상학납입화배제표준진행평개。결과:본조사사적105례자궁기류환자중,년령36-49세,평균년령45.7세。체내유절육배1례화하복부유명현파흔1례피직접배제。103례행자공진평소검사,87례행자공진증강검사;기류단발87례,기중I형54례,II형27례,III형6례;다발12례,기중I형7례,II형3례,III형2례,6례피배제。단발병례중자궁기류위치편후,고근저골5례,기류중심거피부≥10cm적7례;자궁선기증4례;초성취초야내유장관무법피개2례;T2가권상현시고신호화혼잡신호적자궁기류38례。합계배제62례,배제솔59.05%。43례납입MR-HIFU치료,입조솔40.95%。결론:통과대자궁기류환자적자공진영상학사사표준적건립,제고료MR-HIFU치료적안전성。
Objective: The significance for establishing the imaging screening criteria for patients before we use Magnetic Resonance -guided high-intensity focused ultrasound ablation therapy. Methods: Collecting one hundred and five child-bearing age women patients who clinically diagnosed as uterine fibroid, born and pre-menopausal from our hospital since the 2012-09 to 2013-012, for enrolled patients, we performed MR exam, meanwhile evaluating according to clinical and imaging inclusion and exclusion criteria. Results: Among 105 patients with uterine fibroid our team screened, whose age is from 36 to 49, average age is 45.7.one with intrauterine contraceptive ring and another with obvious scar in lower abdomen were directly excluded. One hundred and three patients underwent MR plain scan, eight-seven patients underwent MR enhanced scan; Among eight-seven patients with single fibroid,there are fifty-four type I, twenty-seven type II, six type III; twelve patients have multiple fibroid, there are seven type I, three type II, two type III, six patients were excluded. Among patients with single fibroid, five patients with fibroid locating posteriorly, close to sacrum, seven patients with the distance from the center of fibroid to skin is greater than or equal to ten centimeter, four ones suffering from adenomyosis; there is unavoidable bowel in ultrasonic focusing field for two patients; thirty-seven examples with fibroid displaying as high and mixed signal in MR T2-weighted image. We totally excluded sixty-two patients, the exclusion ratio is 59.05%. Forty-three ones are included for Magnetic Resonance-guided high-intensity focused ultrasound ablation therapy, the enrollment ratio is 40.95%. Conclusions: Through building Magnetic Resonance Imaging screening criteria for patients suffering from uterine fibroids, the safety of MR-HIFU ablation therapy has been enhanced.